Middle East & Africa Immunodiagnostics Market to 2030 - By Size, Share, Growth by End User and Forecast

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Middle East & Africa Immunodiagnostics Market – by Product

1.3.2 Middle East & Africa Immunodiagnostics Market – by Clinical Indication

1.3.3 Middle East & Africa Immunodiagnostics Market – by End User

1.3.4 Middle East & Africa Immunodiagnostics Market – by Country

2. Middle East & Africa Immunodiagnostics Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Middle East & Africa Immunodiagnostics Market – Market Landscape

4.1 Overview

4.2 Middle East & Africa PEST Analysis

4.3 Expert’s Opinion

5. Middle East & Africa Immunodiagnostics Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Increasing Prevalence of Infectious Diseases

5.1.2 Growing Use of Point-of-Care Immunodiagnostics

5.2 Market Restraints

5.2.1 Inadequate Reimbursement Scenario

5.3 Market Opportunities

5.3.1 Rising Focus on R&D Investment and Expansion by Key Players

5.4 Future Trends

5.4.1 Technological Advancements in Immunodiagnostics

5.5 Impact Analysis

6. Immunodiagnostics Market – Middle East & Africa Analysis

6.1 Middle East & Africa Immunodiagnostics Market Revenue Forecast and Analysis

7. Middle East & Africa Immunodiagnostics Market Analysis – by Product

7.1 Overview

7.2 Middle East & Africa Immunodiagnostics Market, By Product, 2022 & 2030 (%)

7.3 Enzyme-linked Immunosorbent Assays (ELISA)

7.3.1 Overview

7.3.2 Enzyme-linked Immunosorbent Assays (ELISA): Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

7.4 Chemiluminescence Immunoassays (CLIA)

7.4.1 Overview

7.4.2 Chemiluminescence Immunoassays (CLIA): Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

7.4.3 Vitamin D Assay

7.4.3.1 Overview

7.4.3.2 Vitamin D Assay: Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

7.4.4 HIV Detection

7.4.4.1 Overview

7.4.4.2 HIV Detection: Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

7.4.5 HIV Ag/Ab Combo assay

7.4.5.1 Overview

7.4.5.2 HIV Ag/Ab Combo Assay: Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

7.4.6 Other Tests

7.4.6.1 Overview

7.4.6.2 Other Tests: Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

7.5 Radioimmunoassays (RIA)

7.5.1 Overview

7.5.2 Radioimmunoassays (RIA): Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

7.6 Others

7.6.1 Overview

7.6.2 Others: Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

8. Middle East & Africa Immunodiagnostics Market Analysis – Clinical Indication

8.1 Overview

8.2 Middle East & Africa Immunodiagnostics Market Share by Clinical Indication - 2022 & 2030 (%)

8.3 Infectious Diseases:

8.3.1 Overview

8.3.2 Infectious Diseases: Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

8.3.2.1 COVID-19

8.3.2.1.1 Overview

8.3.2.1.2 COVID-19: Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

8.3.2.2 Tuberculosis

8.3.2.2.1 Overview

8.3.2.2.2 Tuberculosis: Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

8.3.2.3 Lyme

8.3.2.3.1 Overview

8.3.2.3.2 Lyme: Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

8.3.2.4 Infection Management

8.3.2.4.1 Overview

8.3.2.4.2 Infection Management: Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

8.3.2.5 Zika

8.3.2.5.1 Overview

8.3.2.5.2 Zika: Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

8.3.2.6 Treponema

8.3.2.6.1 Overview

8.3.2.6.2 Treponema: Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

8.3.2.7 TORCH

8.3.2.7.1 Overview

8.3.2.7.2 TORCH: Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

8.3.2.8 Measles and Mumps

8.3.2.8.1 Overview

8.3.2.8.2 Measles and Mumps: Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

8.3.2.9 VZV

8.3.2.9.1 Overview

8.3.2.9.2 VZV: Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

8.3.2.10 EBV

8.3.2.10.1 Overview

8.3.2.10.2 EBV: Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

8.4 Hepatitis+HIV:

8.4.1 Overview

8.4.2 Hepatitis+HIV: Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

8.5 Gastrointestinal

8.5.1 Overview

8.5.2 Gastrointestinal: Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

8.6 Metabolic Disorders

8.6.1 Overview

8.6.2 Metabolics: Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

8.7 Endocrinology

8.7.1 Overview

8.7.2 Endocrinology: Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

8.7.3 Hypertension

8.7.3.1 Overview

8.7.3.2 Hypertension: Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

8.7.4 Growth

8.7.4.1 Overview

8.7.4.2 Growth: Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

8.7.5 Diabetes

8.7.5.1 Overview

8.7.5.2 Diabetes: Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

8.7.6 Thyroid

8.7.6.1 Overview

8.7.6.2 Thyroid: Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

8.7.7 Reproductive Endocrinology

8.7.7.1 Overview

8.7.7.2 Reproductive Endocrinology: Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

8.8 Others

8.8.1 Overview

8.8.2 Others: Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

9. Middle East & Africa Immunodiagnostics Market Analysis – End User

9.1 Overview

9.2 Middle East & Africa Immunodiagnostics Market Share by End User - 2022 & 2030 (%)

9.3 Hospitals

9.3.1 Overview

9.3.2 Hospitals: Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

9.4 Clinics

9.4.1 Overview

9.4.2 Clinics: Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

9.5 Diagnostic Laboratories

9.5.1 Overview

9.5.2 Diagnostic Laboratories: Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

9.6 Academic and Research Institutes

9.6.1 Overview

9.6.2 Academic and Research Institutes: Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

9.7 Others

9.7.1 Overview

9.7.2 Others: Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

10. Middle East & Africa Immunodiagnostics Market – Revenue and Forecast to 2030 – Country Analysis

10.1 Overview

10.1.1.1 UAE: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.1.1 Overview

10.1.1.1.2 UAE: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.1.3 UAE: Immunodiagnostics Market, by Product, 2020–2030 (US$ Million)

10.1.1.1.3.1 UAE: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)

10.1.1.1.4 UAE: Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)

10.1.1.1.4.1 UAE: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)

10.1.1.1.4.2 UAE: Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)

10.1.1.1.5 UAE: Immunodiagnostics Market, by End User, 2020–2030 (US$ Million)

10.1.1.2 Saudi Arabia: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.2.1 Overview

10.1.1.2.2 Saudi Arabia: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.2.3 Saudi Arabia: Immunodiagnostics Market, by Product, 2020–2030 (US$ Million)

10.1.1.2.3.1 Saudi Arabia: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)

10.1.1.2.4 Saudi Arabia: Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)

10.1.1.2.4.1 Saudi Arabia: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)

10.1.1.2.4.2 Saudi Arabia: Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)

10.1.1.2.5 Saudi Arabia: Immunodiagnostics Market, by End User, 2020–2030 (US$ Million)

10.1.1.3 South Africa: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.3.1 Overview

10.1.1.3.2 South Africa: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.3.3 South Africa: Immunodiagnostics Market, by Product, 2020–2030 (US$ Million)

10.1.1.3.3.1 South Africa: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)

10.1.1.3.4 South Africa: Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)

10.1.1.3.4.1 South Africa: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)

10.1.1.3.4.2 South Africa: Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)

10.1.1.3.5 South Africa: Immunodiagnostics Market, by End User, 2020–2030 (US$ Million)

10.1.1.4 Rest of Middle East & Africa: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.4.1 Overview

10.1.1.4.2 Rest of Middle East & Africa: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.4.3 Rest of Middle East & Africa: Immunodiagnostics Market, by Product, 2020–2030 (US$ Million)

10.1.1.4.3.1 Rest of Middle East & Africa: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)

10.1.1.4.4 Rest of Middle East & Africa: Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)

10.1.1.4.4.1 Rest of Middle East & Africa: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)

10.1.1.4.4.2 Rest of Middle East & Africa: Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)

10.1.1.4.5 Rest of Middle East & Africa: Immunodiagnostics Market, by End User, 2020–2030 (US$ Million)

11. Middle East & Africa Immunodiagnostics Market –Industry Landscape

11.1 Overview

11.2 Inorganic Growth Strategies

11.2.1 Overview

11.3 Organic Growth Strategies

11.3.1 Overview

12. Company Profiles

12.1 Abbott Laboratories

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Products and Services

12.1.4 Financial Overview

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 F. Hoffmann-La Roche Ltd

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Products and Services

12.2.4 Financial Overview

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 DiaSorin SpA

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Products and Services

12.3.4 Financial Overview

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 Danaher Corp

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6 Key Developments

12.5 Thermo Fisher Scientific Inc

12.5.1 Key Facts

12.5.2 Business Description

12.5.3 Products and Services

12.5.4 Financial Overview

12.5.5 SWOT Analysis

12.5.6 Key Developments

12.6 PerkinElmer Inc

12.6.1 Key Facts

12.6.2 Business Description

12.6.3 Products and Services

12.6.4 Financial Overview

12.6.5 SWOT Analysis

12.6.6 Key Developments

12.7 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

12.7.1 Key Facts

12.7.2 Business Description

12.7.3 Products and Services

12.7.4 Financial Overview

12.7.5 SWOT Analysis

12.7.6 Key Developments

12.8 bioMerieux SA

12.8.1 Key Facts

12.8.2 Business Description

12.8.3 Products and Services

12.8.4 Financial Overview

12.8.5 SWOT Analysis

12.8.6 Key Developments

12.9 Svar Life Science AB

12.9.1 Key Facts

12.9.2 Business Description

12.9.3 Products and Services

12.9.4 Financial Overview

12.9.5 SWOT Analysis

12.9.6 Key Developments

12.10 Siemens Healthcare GmbH

12.10.1 Key Facts

12.10.2 Business Description

12.10.3 Products and Services

12.10.4 Financial Overview

12.10.5 SWOT Analysis

12.10.6 Key Developments

13. Appendix

13.1 About The Insight Partners

13.2 Glossary of Terms

LIST OF TABLES

Table 1. UAE Immunodiagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million)

Table 2. UAE Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)

Table 3. UAE Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)

Table 4. UAE Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)

Table 5. UAE Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)

Table 6. UAE Immunodiagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)

Table 7. Saudi Arabia Immunodiagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million)

Table 8. Saudi Arabia Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)

Table 9. Saudi Arabia Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)

Table 10. Saudi Arabia: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)

Table 11. Saudi Arabia Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)

Table 12. Saudi Arabia Immunodiagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)

Table 13. South Africa Immunodiagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million)

Table 14. South Africa Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)

Table 15. South Africa Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)

Table 16. South Africa: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)

Table 17. South Africa Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)

Table 18. South Africa Immunodiagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)

Table 19. Rest of Middle East & Africa Immunodiagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million)

Table 20. Rest of Middle East & Africa Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)

Table 21. Rest of Middle East & Africa Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)

Table 22. Rest of Middle East & Africa: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)

Table 23. Rest of Middle East & Africa Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)

Table 24. Rest of Middle East & Africa Immunodiagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)

Table 25. Recent Inorganic Growth Strategies in the Middle East & Africa immunodiagnostics market

Table 26. Recent Organic Growth Strategies in the Middle East & Africa immunodiagnostics market

Table 27. Glossary of Terms, Middle East & Africa Immunodiagnostics Market

LIST OF FIGURES

Figure 1. Middle East & Africa Immunodiagnostics Market Segmentation

Figure 2. Middle East & Africa Immunodiagnostics Market, by Country

Figure 3. Middle East & Africa Immunodiagnostics Market Overview

Figure 4. Enzyme-Linked Immunosorbent Assays (ELISA) Segment Held Largest Share of Product Segment in Middle East & Africa Immunodiagnostics Market

Figure 5. UAE Expected to Show Remarkable Growth During Forecast Period

Figure 6. Middle East & Africa: PEST Analysis

Figure 7. Experts’ Opinion

Figure 8. Middle East & Africa Immunodiagnostics Market: Impact Analysis of Drivers and Restraints

Figure 9. Middle East & Africa Immunodiagnostics Market – Revenue Forecast and Analysis – 2021–2030

Figure 10. Middle East & Africa Immunodiagnostics Market, by Product, 2022 & 2030 (%)

Figure 11. Enzyme-linked Immunosorbent Assays (ELISA): Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 12. Chemiluminescence Immunoassays (CLIA): Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 13. Vitamin D Assay: Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 14. HIV Detection: Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 15. HIV Ag/Ab Combo Assay: Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 16. Other Tests: Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 17. Radioimmunoassays (RIA): Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 18. Others: Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 19. Middle East & Africa Immunodiagnostics Market Share by Clinical Indication - 2022 & 2030 (%)

Figure 20. Infectious Diseases: Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 21. COVID-19: Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 22. Tuberculosis: Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 23. Lyme: Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 24. Infection Management: Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 25. Zika: Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 26. Treponema: Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 27. TORCH: Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 28. Measles and Mumps: Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 29. VZV: Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 30. EBV: Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 31. Hepatitis+HIV: Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 32. Gastrointestinal: Middle East & Africa Immunodiagnostics Market Revenue and Forecasts to 2030 (US$ Million)

Figure 33. Metabolics: Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 34. Endocrinology: Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 35. Hypertension: Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 36. Growth: Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 37. Diabetes: Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 38. Thyroid: Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 39. Reproductive Endocrinology: Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 40. Endocrinology: Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 41. Middle East & Africa Immunodiagnostics Market Share by End User - 2022 & 2030 (%)

Figure 42. Hospitals: Middle East & Africa Immunodiagnostics Market Revenue and Forecasts to 2030 (US$ Million)

Figure 43. Clinics: Middle East & Africa Immunodiagnostics Market Revenue and Forecasts To 2030 (US$ Million)

Figure 44. Diagnostic Laboratories: Middle East & Africa Immunodiagnostics Market Revenue and Forecasts to 2030 (US$ Million)

Figure 45. Academic and Research Institutes: Middle East & Africa Immunodiagnostics Market Revenue and Forecasts to 2030 (US$ Million)

Figure 46. Others: Middle East & Africa Immunodiagnostics Market Revenue and Forecasts to 2030 (US$ Million)

Figure 47. Middle East & Africa Immunodiagnostics Market, by Key Country – Revenue (2022) (US$ Million)

Figure 48. Middle East & Africa: Immunodiagnostics Market, by Country, 2022 & 2030 (%)

Figure 49. UAE: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 50. Saudi Arabia: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 51. South Africa: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 52. Rest of Middle East & Africa: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)